Aspira Pathlab & Diagnostics Limited reported earnings results for the full year ended March 31, 2024. For the full year, the company reported sales was INR 132.05 million compared to INR 144.57 million a year ago. Revenue was INR 136.26 million compared to INR 147.78 million a year ago.

Net loss was INR 26.72 million compared to INR 0.887 million a year ago. Basic loss per share from continuing operations was INR 2.6 compared to INR 0.09 a year ago. Diluted loss per share from continuing operations was INR 2.6 compared to INR 0.09 a year ago.